Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Antonello

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Contributions to Nephrology|January 1, 1997
Constitutive nitric oxide synthase gene expression in Bartter's and Gitelman's syndrome and its relationship to their vascular hyporesponsivenessL Calò, M C Bordin, P A Davis, et al.
American Journal of Nephrology|January 1, 1997
Is the red cell morphology really useful to detect the source of hematuria?S Favaro, L Bonfante, A D'Angelo, et al.
Clinical Nephrology|May 16, 2000
Oxidative stress and nitric oxide system in post-transplant hypertensionL Calò, R Marcon, P Rigotti, et al.
Transplantation Proceedings|October 1, 1994
Pre- and postoperative evaluation of vascular resistance in living related renal allografts under cyclosporine infusionP Rigotti, D Sacerdoti, M Bolognesi, et al.
Sarcoma|April 18, 2020
Induction of Myogenic Differentiation Improves Chemosensitivity of Chemoresistant Cells in Soft-Tissue Sarcoma Cell LinesLucy E Dawson, Luca D'Agostino, Abraham A Hakim, et al.
Clinical Nephrology|May 16, 2000
Parathyroid hormone and bone metabolism in kidney-transplanted patientsA D'Angelo, L Calò, S Giannini, et al.
Clinical Nephrology|January 5, 2002
Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantationS Giannini, A D'Angelo, G Carraro, et al.
Oncotarget|November 22, 2017
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF<sup>V600E</sup>Zeus A Antonello, Nancy Hsu, Manoj Bhasin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2018
Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 AxisAlessandro Prete, Agnes S Lo, Peter M Sadow, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1996
Carotid artery lesions in patients with nondiabetic chronic renal failureA Rossi, L Bonfante, A Giacomini, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Contributions to Nephrology|January 1, 1997
Constitutive nitric oxide synthase gene expression in Bartter's and Gitelman's syndrome and its relationship to their vascular hyporesponsivenessL Calò, M C Bordin, P A Davis, et al.
American Journal of Nephrology|January 1, 1997
Is the red cell morphology really useful to detect the source of hematuria?S Favaro, L Bonfante, A D'Angelo, et al.
Clinical Nephrology|May 16, 2000
Oxidative stress and nitric oxide system in post-transplant hypertensionL Calò, R Marcon, P Rigotti, et al.
Transplantation Proceedings|October 1, 1994
Pre- and postoperative evaluation of vascular resistance in living related renal allografts under cyclosporine infusionP Rigotti, D Sacerdoti, M Bolognesi, et al.
Sarcoma|April 18, 2020
Induction of Myogenic Differentiation Improves Chemosensitivity of Chemoresistant Cells in Soft-Tissue Sarcoma Cell LinesLucy E Dawson, Luca D'Agostino, Abraham A Hakim, et al.
Clinical Nephrology|May 16, 2000
Parathyroid hormone and bone metabolism in kidney-transplanted patientsA D'Angelo, L Calò, S Giannini, et al.
Clinical Nephrology|January 5, 2002
Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantationS Giannini, A D'Angelo, G Carraro, et al.
Oncotarget|November 22, 2017
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAF<sup>V600E</sup>Zeus A Antonello, Nancy Hsu, Manoj Bhasin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2018
Pericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 AxisAlessandro Prete, Agnes S Lo, Peter M Sadow, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 1, 1996
Carotid artery lesions in patients with nondiabetic chronic renal failureA Rossi, L Bonfante, A Giacomini, et al.
Pageof 9